Plum-blossom needle therapy for Tourette syndrome: A case report.

Tourette syndrome (TS) causes involuntary movements and sounds called tics, which typically begin in childhood. While medications exist, many families worry about their side effects. This case report describes an 11-year-old boy with Tourette syndrome who experienced significant improvement using plum-blossom needle therapy, a traditional Chinese acupuncture technique.

The boy had suffered from TS for over five years, experiencing frequent throat clearing, eye blinking, severe abdominal tensing, shoulder shrugging, and arm twitching. He received plum-blossom needle therapy twice weekly for eight weeks. This technique uses a small hammer-like tool with multiple tiny needles that gently tap the skin, making it well-tolerated by children who may be anxious about traditional needle insertion.

The results were impressive. Using the Yale Global Tic Severity Scale, the boy's tic severity dropped from 71 to 20—a dramatic reduction. His overall improvement was rated as "very much improved" by clinicians. His tic symptoms became minimal by the end of treatment. Interestingly, while his tics improved significantly, his quality of life scores remained relatively stable, suggesting the therapy primarily targeted physical symptoms.

This case adds to growing evidence that plum-blossom needle therapy may offer a safe, child-friendly option for managing Tourette syndrome. The gentle nature of this technique makes it particularly suitable for pediatric patients. However, this is just one patient's experience. Researchers emphasize that larger clinical trials are needed to confirm these findings and establish clear treatment guidelines. If you're considering acupuncture for Tourette syndrome, seek a licensed acupuncturist with specialized training in pediatric care and traditional Chinese medicine techniques.

This case report documents an 11-year-old male with chronic Tourette syndrome treated with plum-blossom needle therapy (PBNT) over 8 weeks (16 sessions total, twice weekly). The patient presented with multiple motor and vocal tics including throat clearing, eye blinking, abdominal tensing, shoulder shrugging, and upper limb twitching persisting over five years.

Primary outcome measures included the Yale Global Tic Severity Scale (YGTSS), which decreased substantially from 71 to 20 post-treatment, and the TS Clinical Global Impression Scale of Improvement (CGI-I), which scored 1 ("very much improved"). Secondary outcome measurement via the Children and Adolescents' Quality of Life Scale (CAQOL) showed minimal change (146 to 150).

The dramatic YGTSS reduction represents a clinically significant improvement in tic severity and frequency. PBNT demonstrated excellent pediatric tolerability. Clinical implications suggest PBNT may serve as a viable, low-risk intervention for pediatric TS, particularly for families seeking alternatives to pharmacotherapy. However, as a single-case observation without controls, these findings require validation through adequately powered randomized controlled trials before definitive clinical recommendations can be established regarding treatment protocols, optimal frequency, and duration.